Please login to the form below

Not currently logged in
Email:
Password:

Former Bausch + Lomb CEO to lead Forest Labs

Brenton Saunders succeeds Howard Solomon who steps down after 36 years

Forest Labs Brenton Brent SaundersForest Laboratories has named the former head of Bausch + Lomb, Brenton Saunders, as the company's new CEO and president, effective October 1.

He succeeds Howard Solomon, who has been one of the longest serving CEOs in the pharma industry, having been in his role at Forest since 1977.

Saunders, who has been a director at Forest for the past two years, described his predecessor as an “industry icon”.

“I have deep admiration for him and look forward to his continued counsel as we take Forest into the future,” he said.

At just 43, Saunders is relatively young among pharma CEOs, but he has plenty of senior experience, serving as head of Bausch + Lomb from 2010 to August 2013, during which time the eyecare specialist was purchased by Valeant Pharmaceuticals for $8.7bn.

Prior to this, he spent six years at Schering-Plough, serving in several senior positions including president of global consumer healthcare. While at Schering-Plough he also served as integrations head for the company's acquisition in 2007 of Organon BioSciences and during the company's 2009 merger with Merck & Co.

Saunders has a background in economics, and his experience prior to joining the pharma industry includes time as a partner at PricewaterhouseCoopers and as senior VP, compliance, legal and regulatory at Homecare Corporation of America.

Kenneth Goodman, who was a member of Forest's committee of independent directors to pick a successor to Solomon, said that they had been considering Saunders as a likely candidate for a long time.

“We are delighted that, following the recent sale of Bausch + Lomb, Brent became available at just the right time,” he said. “He is strategic, innovative, experienced and the right leader for Forest today,” Goodman said.

13th September 2013

From: Research, Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....